Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3089-3096

  Sun, Z ^a   Zhu, P ^a   Li, L ^a   Wan, Z ^a   Zhao, Z ^a   Li, R ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASP F16 PEPTIDE; CD8 ANTIGEN; FUNGUS ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONIDIUM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FUNGUS HYPHAE; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME; TH1 CELL; TRANSGENIC MOUSE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGENS; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSPOT ASSAY; FUNGAL PROTEINS; HLA-A2 ANTIGEN; HYPHAE; IMMUNIZATION, PASSIVE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPORES, FUNGAL; SURVIVAL ANALYSIS; TH1 CELLS;

EID: 84867984719     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1670-2     Document Type: Article

References (25)

1. Marr KA, Patterson T, Denning D (2002) Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 16:875-894, vi
2. Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310-350
3. Iversen M, Burton CM, Vand S, Skovfoged L, Carlsen J, Milman N, Andersen CB, Rasmussen M, Tvede M (2007) Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 26:879-886
4. Wang W, Zhao CY, Zhou JY, Wang YD, Shen C, Zhou DF, Yin HZ (2011) Invasive pulmonary aspergillosis in patients with HBV-related liver failure. Eur J Clin Microbiol Infect Dis 30:661-667
5. Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L (2000) T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 165:381-388
6. Stevens DA (2004) Vaccinate against aspergillosis! A call to arms of the immune system. Clin Infect Dis 38:1131-1136
7. Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV (2005) Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 105:2258-2265
8. Asif AR, Oellerich M, Amstrong VW, Riemenschneider B, Monod M, Reichard U (2006) Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J Proteome Res 5:954-962
9. Pizza M, Scarlato V, Masignani V, Giuliani MM, Aricò B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816-1820
10. Chaudhary N, Staab JF, Marr KA (2010) Healthy human T-cell responses to Aspergillus fumigatus antigens. PLoS One 5:e9036
11. Bozza S, Gaziano R, Lipford GB, Montagnoli C, Bacci A, Di Francesco P, Kurup VP, Wagner H, Romani L (2002) Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 4:1281-1290
12. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA (2005) Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 140:81-91
13. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA (2005) Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 139:257-267
14. Zhang L, Wang M, Li R, Calderone R (2005) Expression of Aspergillus fumigatus virulence-related genes detected in vitro and in vivo with competitive RT-PCR. Mycopathologia 160:201-206
15. Alvarez CA, Wiederhold NP, McConville JT, Peters JI, Najvar LK, Graybill JR, Coalson JJ, Talbert RL, Burgess DS, Bocanegra R, Johnston KP, Williams RO 3rd (2007) Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis. J Infect 55:68-74
16. Melief CJ, van der Burg SH (2008) Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines. Nat Rev Cancer 8:351-360
17. Aichele P, Hengartner H, Zinkernagel RM, Schulz M (1990) Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med 171:1815-1820
18. Sangha R, Butts C (2007) L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin Cancer Res 13:s4652-s4654
19. Bär E, Gladiator A, Bastidas S, Roschitzki B, Acha-Orbea H, Oxenius A, Leibundgut-Landmann S (2012) A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J Immunol 188:5636-5643
20. Kullberg BJ (1997) Trends in immunotherapy of fungal infections. Eur J Clin Microbiol Infect Dis 16:51-55
21. Ma LL, Spurrell JC, Wang JF, Neely GG, Epelman S, Krensky AM, Mody CH (2002) CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J Immunol 169:5787-5795
22. Huang LP, Lyu SC, Clayberger C, Krensky AM (2007) Granulysin-mediated tumor rejection in transgenic mice. J Immunol 178:77-84
23. Pini G, Faggi E, Donato R, Sacco C, Fanci R (2008) Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses 51:117-122
24. Wuthrich M, Filutowicz HI, Warner T, Deepe GS Jr, Klein BS (2003) Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 197:1405-1416
25. Stephens-Romero SD, Mednick AJ, Feldmesser M (2005) The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 73:114-125